alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › matrix-metalloproteinases

matrix-metalloproteinases

3 studies tagged matrix-metalloproteinases, dated 2011-01-01 to 2022-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type 2022-07-01
  2. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease 2014-01-01
  3. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease 2011-01-01

Studies

3 studies carry this tag.

Date range

2011 to 2022

Top journals

  • Journal of Alzheimer's disease : JAD 2
  • Brain : a journal of neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Brain : a journal of neurology 2022-07-01 Biomarkers

    Alzheimer's disease has a long asymptomatic phase that offers a substantial time window for intervention.

  2. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of Alzheimer's disease : JAD 2014-01-01 Biomarkers

    Altered concentrations of two out of three MMPs investigated in this study suggest that this family of biomolecules may play a role in the AD pathophysiology.

  3. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of Alzheimer's disease : JAD 2011-01-01 Biomarkers

    Alzheimer's disease (AD) and vascular dementia (VaD) are intertwined by mixed dementia (MD) harboring varying degrees of AD pathology in combination with cerebrovascular disease.

All topic tags with their study counts